EBITDA Margin ratio Analysis of Catalyst Biosciences Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EBITDA Margin
Period Ending - Dec-22
Very Poor EBITDA Margin
-874.94
Period Ending - Dec-21
Very Poor EBITDA Margin
-1193.84
Growth
26.71 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-22
Excellent EBITDA Margin
767.13
Most recent Quarter EBITDA Margin
Period Ending - Sep-23
Poor EBITDA Margin
0
EBITDA Margin Analysis of Catalyst Biosciences Inc
| Ebitda Margin Ratio of Catalyst Biosciences Inc with value of 767.13 means that its operating expenses are lower in relation to total revenue in trailing twelve months. |
| EBITDA Margin Ratio of CBIO rose handsomely by 26.71 % this year. |
| EBITDA Margin Ratio with value of 0 was highest in Year Dec-19 in last Five Years. |
| EBITDA Margin Ratio with value of -498433.33 was lowest in Year Dec-18 in last Five Years. |
| Latest EBITDA Margin Ratio with value of -874.94 is Greater than Average EBITDA Margin of -100153.99 in last five years. |
| Ebitda Margin of Catalyst Biosciences Inc is negative because of negative EBITDA in FY ended on Dec-22. |
Other EBITDA Margin Related Info of CBIO that may interest you.
Catalyst Biosciences Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| CBIO | 23.31 | 0.5113 | 4458.97 % | Biotechnology |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..
EBITDA Margin Related Ratios
| NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
| Low Profitability Stock | |
FY - Historical EBITDA Margin of Catalyst Biosciences Inc
| Period | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|
| EBITDA Margin | -874.94 | -1193.84 | -267.82 | 0 | -498433.33 | -2100.98 | -4149.37 |
| Change | 26.71 % | -345.76 % | 0 % | -23623.82 % | 49.37 % | -466.68 % |
FY Chart of EBITDA Margin of Catalyst Biosciences Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)